Dr. Sheeja Pullarkat, MD
What this data tells you about Dr. Pullarkat
Dr. Sheeja Pullarkat is an anatomic pathology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pullarkat performed 6,626 Medicare services across 1,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pullarkat received a total of $213,828 from 4 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anatomic pathology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pullarkat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
3,802 | $20 | $268 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
762 | $40 | $252 |
| Additional manual multiplex genetic stain A microscopic genetic analysis performed manually using an additional multiplex stain procedure on tissue. |
368 | $187 | $1,131 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
250 | $38 | $191 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
179 | $33 | $280 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
172 | $71 | $435 |
| Flow cytometry, 16 or more markers A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties. |
165 | $71 | $476 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
146 | $55 | $386 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
142 | $46 | $273 |
| Tissue preparation to remove calcium A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination. |
119 | $9 | $60 |
| Manual microscopic genetic analysis of tissue A laboratory test that manually examines tissue samples under a microscope to analyze genetic material. This initial procedure involves direct visual inspection to identify specific genetic characteristics. |
97 | $66 | $552 |
| Additional manual microscopic genetic analysis This procedure involves the manual microscopic examination of tissue samples to perform additional genetic analysis beyond the initial test. |
84 | $57 | $298 |
| Bone marrow smear interpretation A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities. |
53 | $62 | $451 |
| Tissue culture for bone marrow and blood cell tumor disorders A laboratory test that grows bone marrow or blood cells in a culture to analyze tumor disorders. |
53 | $141 | $820 |
| Chromosome analysis for genetic defects A laboratory test that examines 15 to 20 cells to check for genetic defects in the chromosomes. |
53 | $123 | $810 |
| Genetic test interpretation and report A healthcare provider reviews the results of genetic testing and provides a written report explaining the findings. |
53 | $29 | $175 |
| Genetic sequencing localization, initial procedure This procedure involves the initial process of localizing genetic sequencing. It identifies the specific location of genetic material for further analysis. |
34 | $101 | $495 |
| Flow cytometry DNA or cell analysis, 9-15 markers A laboratory test that uses a laser to analyze cells or DNA using 9 to 15 different markers. This technique helps identify and characterize specific cell types or genetic material. |
28 | $53 | $394 |
| Moderately high complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation. |
20 | $70 | $400 |
| Blood smear interpretation with written report A physician examines a blood sample slide under a microscope to analyze blood cells. The doctor provides a written report of their findings. |
18 | $21 | $125 |
| Additional genetic sequencing localization This procedure involves additional genetic sequencing localization work beyond the initial test. It is performed to further analyze genetic material. |
17 | $29 | $200 |
| Additional chromosome analysis study This procedure involves performing an additional karyotype analysis to examine chromosomes for genetic defects. It is billed as a separate study beyond the initial analysis. |
11 | $33 | $160 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2019-2024) ›
Associated products mentioned in payments ›
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anatomic pathology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for anatomic pathology physician in CA.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pullarkat is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pullarkat experienced with flow cytometry, additional marker?
Does Dr. Pullarkat receive payments from pharmaceutical companies?
How do Dr. Pullarkat's costs compare to other anatomic pathology physicians in Los Angeles?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology